Indivior PLC Indivior to Participate in Conference (6290Z)
May 25 2021 - 5:00AM
UK Regulatory
TIDMINDV
RNS Number : 6290Z
Indivior PLC
25 May 2021
Indivior to Participate in Jefferies Virtual Healthcare
Conference
Slough, UK and Richmond, VA - May 25, 2021 - Indivior PLC (LON:
INDV) today announced that Mark Crossley, Chief Executive Officer,
and Ryan Preblick, Chief Financial Officer, will participate in the
Jefferies Virtual Healthcare Conference. Mark Crossley will present
on June 1, 2021, at 10:30 AM (ET). The live presentation will be
available on Indivior's website www.indivior.com and can also be
viewed using the following webcast link:
https://wsw.com/webcast/jeff174/indv.l/2076381 .
About Indivior
Indivior is a global specialty pharmaceutical company with a
20-year legacy of leadership in patient advocacy and health policy
while providing education on evidence-based treatment models that
have revolutionized modern addiction treatment. Our vision is for
all patients around the world to have access to evidence-based
treatment for the chronic conditions and co-occurring disorders of
addiction. The name is the fusion of the words individual and
endeavor, and the tagline "Focus on you" makes the Company's
commitment clear. Indivior is dedicated to transforming addiction
from a global human crisis to a recognized and treated chronic
disease. Building on its global portfolio of opioid dependence
treatments, Indivior has a strong pipeline of product candidates
designed to both expand on its heritage in this category and
address other chronic conditions and co-occurring disorders of
addiction, including alcohol use disorder and schizophrenia.
Headquartered in the United States in Richmond, VA, Indivior
employs more than 800 individuals globally and its portfolio of
products is available in over 40 countries worldwide. Visit
www.indivior.com to learn more. Connect with Indivior on LinkedIn
by visiting www.linkedin.com/company/indivior .
Contact :
Jason Thompson
804-402-7123
Vice President, Investor Relations
jason.thompson@indivior.com
###
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCEALSLAEEFEFA
(END) Dow Jones Newswires
May 25, 2021 05:00 ET (09:00 GMT)
Indivior (LSE:INDV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Indivior (LSE:INDV)
Historical Stock Chart
From Apr 2023 to Apr 2024